[Combination radiotherapy-immunotherapy in genitourinary cancer]

Abstract

Immunotherapy occupies a growing place in urologic oncology, mainly for kidney and bladder cancers. On the basis of encouraging preclinical work, the combination of immunotherapy with radiotherapy aims to increase the tumor response, including in metastatic tumors, which raises many hopes, which this article reviews.

Keywords: Bladder cancer; CTLA4; Cancer de la vessie; Cancer du rein; Immune check point inhibition; Inhibition des points de contrôle immunitaire; Kidney cancer; Néoplasme de la prostate; PD1; PDL1; PDL1, CTLA4; Prostate neoplasm; Radiation oncology; Radio-oncologie; Radiothérapie stéréotaxique; Stereotactic body radiation therapy.